Open Access. Powered by Scholars. Published by Universities.®
Social and Behavioral Sciences Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Publication
- Publication Type
Articles 1 - 3 of 3
Full-Text Articles in Social and Behavioral Sciences
Trait Selection And Welfare Of Genetically Engineered Animals In Agriculture, Michael Greger
Trait Selection And Welfare Of Genetically Engineered Animals In Agriculture, Michael Greger
Genetics Collection
The release of the Final Guidance from the US Food and Drug Administration on the commercialization of genetically engineered animals has sparked renewed discussion over the ethical, consumer, and regulatory implications of transgenesis in animal agriculture. Animal welfare critiques have focused on unexpected phenotypic effects in animals used in transgenic research, rather than on the health and welfare implications of the intended productivity enhancement. Unless breeding goals are redefined to reflect social concerns, the occurrence and magnitude of undesirable side effects may increase and consumer confidence in the nascent technology may be undermined.
Engineering A New Form Of Enclosure: International Convergence In Gmo Regulation, Jessica Altif
Engineering A New Form Of Enclosure: International Convergence In Gmo Regulation, Jessica Altif
Electronic Theses and Dissertations
As society begins to recognize its impact on ecological systems, the belief that modern political institutions can offer a sense of control and certainty, as well as protect the health of its citizens, is increasingly questioned. In an era of uncertainty, faith in science and technology to alleviate industrial impacts on the environment is often embraced by policymakers yet questioned by the public who see the authoritative role of the sciences in the political sphere as contributing to global risk. The development of biotechnology, specifically genetically modified food, places an anthropocentric focus on resolving and/or adapting to environmental degradation, further …
Evaluating The Target Pipeline In A Pharmaceutical Acquisition, Daniel Vass
Evaluating The Target Pipeline In A Pharmaceutical Acquisition, Daniel Vass
Business and Economics Honors Papers
Many firms in the pharmaceutical industry turn to acquisitions when faced with gaps in their drug development pipelines and patent expirations as an alternative to making long-term investments in internal research and development. Investors are generally negative on this strategy, and upon the announcement of a pharmaceutical acquisition the stock of the acquiring firm often drops. This decline in share price creates an opportunity for the investor who can identify the characteristics of a target firm that increase the probability that the transaction will ultimately be a success, as measured by the subsequent appreciation in the acquirer's stock. It is …